CYCLOBENZAPRINE HYDROCHLORIDE

CYCLOBENZAPRINE HYDROCHLORIDE was reported 9396 times

CYCLOBENZAPRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TEMPERATURE REGULATION DISORDER 337 0.1511
1 SEDATION COMPLICATION 242 0.0948
2 CREATININE RENAL CLEARANCE DECREASED 241 0.0602
3 FOOD ALLERGY 398 0.0515
4 MULTIPLE DRUG THERAPY 37 0.0491
5 CREATININE RENAL CLEARANCE INCREASED 28 0.0374
6 FOETAL DEATH 193 0.0372
7 COELIAC DISEASE 340 0.0346
8 BURSITIS 374 0.0308
9 IMMUNODEFICIENCY 411 0.0275
10 BLOOD CALCIUM DECREASED 247 0.0219
11 BURNING SENSATION MUCOSAL 7 0.0198
12 BLEPHAROSPASM 124 0.0197
13 INFUSION SITE DISCHARGE 34 0.0194
14 GROIN INFECTION 10 0.0182
15 BONE MARROW INFILTRATION 7 0.0181
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 10 0.0178
17 ALLERGY TO PLANTS 7 0.0153
18 DEVICE MAINTENANCE ISSUE 9 0.0153
19 INFUSION SITE MASS 16 0.0147
20 ORTHOSTATIC HYPOTENSION 251 0.0144
21 PRESCRIBED OVERDOSE 273 0.0141
22 PERIORBITAL PAIN 11 0.0130
23 OVERLAP SYNDROME 8 0.0114
24 SCIATIC NERVE INJURY 9 0.0108
25 RENAL FUNCTION TEST ABNORMAL 49 0.0105
26 UPPER RESPIRATORY TRACT INFECTION 483 0.0104
27 SEDATION 270 0.0103
28 FACET JOINT SYNDROME 33 0.0101
29 CONTRAINDICATED PRODUCT ADMINISTERED 298 0.0098
30 INFUSION SITE HAEMORRHAGE 32 0.0097
31 X-RAY ABNORMAL 17 0.0095
32 DEEP VEIN THROMBOSIS POSTOPERATIVE 18 0.0090
33 RHEUMATIC FEVER 40 0.0090
34 INFUSION SITE BRUISING 19 0.0088
35 LUPUS VULGARIS 11 0.0087
36 INFUSION SITE REACTION 26 0.0087
37 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 20 0.0087
38 CARDIAC DEATH 10 0.0083
39 INFUSION SITE PRURITUS 26 0.0082
40 FLUID RETENTION 417 0.0082
41 RASH ERYTHEMATOUS 385 0.0080
42 DEREALISATION 17 0.0079
43 ONYCHOMADESIS 33 0.0079
44 DEVICE INFUSION ISSUE 19 0.0077
45 PERIPHERAL VENOUS DISEASE 31 0.0076
46 SWOLLEN JOINT COUNT INCREASED 24 0.0075
47 BLOOD PRESSURE DIASTOLIC ABNORMAL 19 0.0075
48 DECREASED IMMUNE RESPONSIVENESS 73 0.0074
49 EYELID PAIN 15 0.0074
50 CATAPLEXY 10 0.0071
51 INFUSION SITE SWELLING 44 0.0070
52 PORPHYRIA ACUTE 10 0.0070
53 TASTE DISORDER 140 0.0069
54 MULTIPLE ALLERGIES 54 0.0069
55 INFUSION SITE INDURATION 10 0.0067
56 HEPATIC ENZYME INCREASED 459 0.0067
57 DEPRESSED LEVEL OF CONSCIOUSNESS 266 0.0067
58 JOINT INSTABILITY 9 0.0064
59 INFUSION SITE ERYTHEMA 53 0.0063
60 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
61 INFUSION SITE IRRITATION 8 0.0062
62 INFUSION SITE PAIN 79 0.0061
63 TUMOUR PAIN 8 0.0061
64 SEASONAL ALLERGY 85 0.0060
65 COGNITIVE DISORDER 279 0.0060
66 OESOPHAGEAL SPASM 11 0.0060
67 INFECTIOUS MONONUCLEOSIS 13 0.0058
68 DISLOCATION OF VERTEBRA 13 0.0057
69 INFUSION SITE INFECTION 13 0.0056
70 VASCULAR DEVICE INFECTION 25 0.0055
71 FINGER DEFORMITY 26 0.0054
72 BLOOD PRESSURE SYSTOLIC ABNORMAL 13 0.0053
73 BACK INJURY 57 0.0052
74 INFUSION RELATED REACTION 343 0.0052
75 PRE-EXISTING CONDITION IMPROVED 31 0.0050
76 PUSTULAR PSORIASIS 17 0.0049
77 OXYGEN SATURATION ABNORMAL 14 0.0049
78 ESSENTIAL HYPERTENSION 9 0.0049
79 RHEUMATOID ARTHRITIS 557 0.0049
80 INSURANCE ISSUE 75 0.0049
81 DIABETES MELLITUS NON-INSULIN-DEPENDENT 7 0.0048
82 HYPERTENSIVE HEART DISEASE 9 0.0048
83 ARTHROPOD STING 8 0.0048
84 GASTRIC DILATATION 8 0.0048
85 FOLLICULITIS 50 0.0048
86 WOUND INFECTION 52 0.0047
87 COMPLEX REGIONAL PAIN SYNDROME 7 0.0047
88 RHEUMATOID FACTOR POSITIVE 27 0.0047
89 CHOREA 8 0.0046
90 BREAST CANCER STAGE III 30 0.0046
91 SPINAL CORD INJURY 8 0.0046
92 DUODENAL ULCER PERFORATION 34 0.0046
93 NAIL DISORDER 40 0.0046
94 ASTHMA 515 0.0046
95 BONE EROSION 16 0.0045
96 HAEMATOLOGICAL INFECTION 11 0.0045
97 PARANASAL SINUS DISCOMFORT 17 0.0045
98 MOBILITY DECREASED 316 0.0044
99 RHINALGIA 12 0.0044
100 SKIN PAPILLOMA 17 0.0042
101 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 30 0.0042
102 EXPOSURE DURING PREGNANCY 260 0.0042
103 EPILEPSY 127 0.0042
104 TONGUE ULCERATION 14 0.0041
105 NEPHROGENIC ANAEMIA 19 0.0041
106 C-REACTIVE PROTEIN ABNORMAL 26 0.0040
107 DRUG INTOLERANCE 391 0.0040
108 HYPERCHOLESTEROLAEMIA 39 0.0040
109 DISTRIBUTIVE SHOCK 9 0.0040
110 DRUG TOLERANCE 20 0.0039
111 SINUS HEADACHE 23 0.0039
112 BALANCE DISORDER 334 0.0039
113 EXOSTOSIS 35 0.0038
114 DENTAL CARE 7 0.0038
115 HYPERHIDROSIS 486 0.0038
116 DERMATITIS CONTACT 43 0.0038
117 FIBROMYALGIA 91 0.0037
118 HYPERVOLAEMIA 18 0.0036
119 OTITIS MEDIA 12 0.0036
120 BACK DISORDER 59 0.0036
121 CATHETER SITE HAEMORRHAGE 9 0.0036
122 HYPERPARATHYROIDISM SECONDARY 9 0.0036
123 RESPIRATORY TRACT CONGESTION 56 0.0035
124 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
125 OBSTRUCTION 14 0.0035
126 FUNCTIONAL GASTROINTESTINAL DISORDER 12 0.0035
127 PRODUCT DISTRIBUTION ISSUE 32 0.0034
128 HYPOAESTHESIA ORAL 52 0.0034
129 RESPIRATORY TRACT INFECTION VIRAL 8 0.0034
130 SPINAL STENOSIS 14 0.0034
131 RETCHING 72 0.0034
132 JOINT SWELLING 405 0.0034
133 DEVICE CONNECTION ISSUE 7 0.0033
134 CONSTIPATION 722 0.0033
135 GRIP STRENGTH DECREASED 29 0.0033
136 CATHETER SITE ERYTHEMA 7 0.0033
137 SCIATICA 52 0.0033
138 INTENTIONAL PRODUCT MISUSE 285 0.0033
139 BLOOD PRESSURE DIASTOLIC DECREASED 24 0.0032
140 MIGRAINE 305 0.0032
141 FIBULA FRACTURE 9 0.0031
142 EYE PAIN 174 0.0031
143 SPINAL OSTEOARTHRITIS 27 0.0031
144 NECK INJURY 9 0.0031
145 WEIGHT FLUCTUATION 32 0.0031
146 EAR PAIN 59 0.0030
147 BLOOD PRESSURE DIASTOLIC INCREASED 14 0.0030
148 MUSCLE INJURY 25 0.0030
149 SYNOVITIS 54 0.0030
150 TREATMENT FAILURE 248 0.0030
151 LIVE BIRTH 25 0.0030
152 SLEEP APNOEA SYNDROME 57 0.0030
153 LIP DRY 27 0.0030
154 GASTROOESOPHAGEAL REFLUX DISEASE 239 0.0030
155 ONYCHOMYCOSIS 13 0.0030
156 SPINAL OPERATION 36 0.0029
157 RESPIRATORY TRACT INFECTION 76 0.0029
158 PRODUCT LABEL CONFUSION 17 0.0029
159 POOR VENOUS ACCESS 30 0.0029
160 PARANASAL SINUS HYPERSECRETION 11 0.0029
161 NECK PAIN 161 0.0029
162 BLOOD BLISTER 9 0.0029
163 DRUG TOLERANCE DECREASED 8 0.0028
164 BACK PAIN 658 0.0028
165 HAND DEFORMITY 37 0.0028
166 HYPERSENSITIVITY 522 0.0028
167 MULTIPLE DRUG OVERDOSE INTENTIONAL 9 0.0028
168 VEIN DISORDER 14 0.0028
169 SINUSITIS 286 0.0028
170 AUTOIMMUNE DISORDER 27 0.0028
171 HYPERTONIC BLADDER 8 0.0028
172 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
173 SKIN ABRASION 13 0.0027
174 DRUG TITRATION ERROR 7 0.0027
175 RED BLOOD CELL SEDIMENTATION RATE INCREASED 30 0.0027
176 LIMB OPERATION 13 0.0027
177 INTERVERTEBRAL DISC DEGENERATION 25 0.0027
178 STREPTOCOCCAL INFECTION 15 0.0027
179 TRIGGER FINGER 11 0.0027
180 OSTEOARTHRITIS 114 0.0027
181 TENDERNESS 28 0.0027
182 EAR INFECTION 71 0.0027
183 IRRITABLE BOWEL SYNDROME 57 0.0027
184 BODY TEMPERATURE DECREASED 26 0.0026
185 PEMPHIGUS 33 0.0026
186 GASTRIC INFECTION 10 0.0026
187 INTERVERTEBRAL DISC PROTRUSION 57 0.0026
188 HYPERLIPIDAEMIA 31 0.0026
189 SPINAL CORD COMPRESSION 10 0.0026
190 GASTROENTERITIS VIRAL 46 0.0025
191 HORDEOLUM 11 0.0025
192 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 43 0.0025
193 HELICOBACTER INFECTION 26 0.0025
194 DRUG SCREEN FALSE POSITIVE 7 0.0025
195 SINUS DISORDER 50 0.0025
196 OBESITY 40 0.0025
197 ILLNESS 258 0.0025
198 RHINITIS ALLERGIC 11 0.0025
199 SPINAL FUSION SURGERY 10 0.0025
200 ANGINA UNSTABLE 16 0.0025
201 HORMONE LEVEL ABNORMAL 12 0.0025
202 TOOTH ABSCESS 25 0.0025
203 CONCUSSION 19 0.0025
204 NODULE 32 0.0024
205 ORAL DISCOMFORT 34 0.0024
206 HEART VALVE INCOMPETENCE 7 0.0024
207 MENISCUS INJURY 15 0.0024
208 SKIN ATROPHY 14 0.0024
209 COMPRESSION FRACTURE 13 0.0024
210 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
211 INFUSION SITE EXTRAVASATION 15 0.0024
212 DEVICE POWER SOURCE ISSUE 7 0.0024
213 GAIT INABILITY 80 0.0024
214 INFECTION 346 0.0024
215 JOINT RANGE OF MOTION DECREASED 32 0.0024
216 SNORING 9 0.0024
217 ARTHRITIS INFECTIVE 11 0.0024
218 WRONG PRODUCT ADMINISTERED 16 0.0024
219 BLOOD PRESSURE SYSTOLIC INCREASED 46 0.0024
220 PRODUCT LABEL ISSUE 16 0.0024
221 SUSPECTED SUICIDE 11 0.0023
222 INTERVERTEBRAL DISC DISORDER 10 0.0023
223 PAIN 1436 0.0023
224 HYPERTENSION 494 0.0023
225 LIGAMENT SPRAIN 23 0.0023
226 PERICARDITIS 39 0.0023
227 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
228 NEURALGIA 56 0.0023
229 RESPIRATORY SYNCYTIAL VIRUS INFECTION 20 0.0023
230 DIABETIC FOOT 7 0.0023
231 THROMBOCYTOPENIA 254 0.0023
232 ROTATOR CUFF SYNDROME 29 0.0023
233 FOOT DEFORMITY 25 0.0023
234 PRODUCTIVE COUGH 107 0.0022
235 FUNGAL SKIN INFECTION 9 0.0022
236 TOOTH INFECTION 29 0.0022
237 HAEMOGLOBIN INCREASED 10 0.0022
238 CORONARY ARTERY STENOSIS 11 0.0022
239 WOUND 61 0.0022
240 NERVE COMPRESSION 20 0.0022
241 PRODUCT USE ISSUE 406 0.0022
242 HEREDITARY ANGIOEDEMA 23 0.0021
243 CARPAL TUNNEL SYNDROME 30 0.0021
244 OCULAR DISCOMFORT 24 0.0021
245 TIBIA FRACTURE 10 0.0021
246 DEAFNESS NEUROSENSORY 7 0.0021
247 SPINAL COLUMN STENOSIS 10 0.0021
248 ERYTHEMA 435 0.0021
249 SKIN LACERATION 23 0.0021
250 POOR PERIPHERAL CIRCULATION 9 0.0021
251 PURULENT DISCHARGE 9 0.0021
252 SCOLIOSIS 13 0.0021
253 KIDNEY INFECTION 41 0.0021
254 THYROID MASS 8 0.0021
255 BLOOD PRESSURE FLUCTUATION 50 0.0021
256 JOINT DISLOCATION 22 0.0021
257 SINUS CONGESTION 28 0.0021
258 ARTHROPATHY 115 0.0021
259 PSORIASIS 270 0.0021
260 ANKLE FRACTURE 32 0.0021
261 PELVIC FRACTURE 16 0.0021
262 TEMPERATURE INTOLERANCE 21 0.0020
263 PHARYNGITIS STREPTOCOCCAL 22 0.0020
264 CARDIOMEGALY 25 0.0020
265 BRONCHITIS 150 0.0020
266 ARTHROPOD BITE 15 0.0020
267 FOOT OPERATION 10 0.0020
268 PHOTOPHOBIA 38 0.0020
269 DIABETIC NEUROPATHY 10 0.0020
270 GASTROINTESTINAL INFECTION 18 0.0020
271 MASS 28 0.0020
272 OSTEOMYELITIS 36 0.0020
273 DEPRESSIVE SYMPTOM 7 0.0020
274 LUPUS-LIKE SYNDROME 18 0.0020
275 SOMNAMBULISM 13 0.0020
276 BRAIN FOG 31 0.0020
277 DYSPHORIA 10 0.0020
278 MUSCLE ATROPHY 25 0.0020
279 THERMAL BURN 14 0.0020
280 GLOSSITIS 7 0.0020
281 DIVERTICULUM 14 0.0020
282 MUSCLE STRAIN 17 0.0020
283 PNEUMONIA BACTERIAL 18 0.0020
284 APPETITE DISORDER 13 0.0020
285 CORONARY ARTERY DISEASE 59 0.0019
286 PRODUCT DOSE OMISSION IN ERROR 55 0.0019
287 POST-TRAUMATIC STRESS DISORDER 13 0.0019
288 HYPOAESTHESIA 290 0.0019
289 SPINAL COMPRESSION FRACTURE 16 0.0019
290 BLOOD CHOLESTEROL INCREASED 90 0.0019
291 POSTOPERATIVE WOUND INFECTION 13 0.0019
292 GLOSSODYNIA 43 0.0019
293 MUSCULOSKELETAL DISCOMFORT 33 0.0019
294 FALL 638 0.0019
295 HYPOTENSION 384 0.0019
296 TOOTH FRACTURE 21 0.0019
297 TONGUE DISCOMFORT 8 0.0019
298 FOREIGN BODY SENSATION IN EYES 12 0.0019
299 ABSCESS LIMB 8 0.0019
300 MUSCULOSKELETAL CHEST PAIN 29 0.0019
301 SKIN INFECTION 21 0.0019
302 SHOULDER OPERATION 8 0.0019
303 RASH VESICULAR 9 0.0019
304 LOCALISED INFECTION 45 0.0019
305 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
306 EYE INFECTION 21 0.0019
307 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
308 AUTOIMMUNE THYROIDITIS 7 0.0018
309 OXYGEN SATURATION DECREASED 104 0.0018
310 POST PROCEDURAL INFECTION 15 0.0018
311 PANCREATIC DISORDER 9 0.0018
312 WALKING AID USER 12 0.0018
313 MEMORY IMPAIRMENT 250 0.0018
314 CORONAVIRUS INFECTION 12 0.0018
315 BLADDER DISORDER 18 0.0018
316 NIGHT SWEATS 58 0.0018
317 TONGUE DISORDER 13 0.0018
318 SPINAL DISORDER 17 0.0018
319 HEADACHE 1125 0.0018
320 PRODUCT DOSE OMISSION ISSUE 527 0.0018
321 LUNG DISORDER 87 0.0018
322 SUSPECTED OFF LABEL USE 8 0.0018
323 LIVER FUNCTION TEST INCREASED 38 0.0018
324 LIMB INJURY 48 0.0018
325 IMPAIRED GASTRIC EMPTYING 24 0.0018
326 URINE ABNORMALITY 8 0.0018
327 ABDOMINAL HERNIA 8 0.0018
328 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
329 FOOT FRACTURE 33 0.0017
330 TOXICITY TO VARIOUS AGENTS 293 0.0017
331 ENURESIS 7 0.0017
332 LARGE INTESTINE POLYP 12 0.0017
333 JOINT INJURY 37 0.0017
334 HYSTERECTOMY 15 0.0017
335 LOWER LIMB FRACTURE 33 0.0017
336 CANDIDA INFECTION 29 0.0017
337 SLEEP DISORDER 121 0.0017
338 WHEEZING 101 0.0017
339 ARTERIOSCLEROSIS 16 0.0017
340 BREAST CANCER STAGE II 14 0.0017
341 FOOD POISONING 9 0.0017
342 PERIPHERAL COLDNESS 23 0.0017
343 OVERDOSE 358 0.0017
344 ADVERSE REACTION 22 0.0017
345 BLISTER 93 0.0017
346 ATELECTASIS 16 0.0017
347 URINARY TRACT INFECTION 282 0.0017
348 RIB FRACTURE 34 0.0017
349 DIZZINESS POSTURAL 16 0.0016
350 RESTLESS LEGS SYNDROME 30 0.0016
351 AORTIC VALVE INCOMPETENCE 7 0.0016
352 END STAGE RENAL DISEASE 30 0.0016
353 TENSION 10 0.0016
354 SURGERY 96 0.0016
355 ORAL DISORDER 12 0.0016
356 CYSTITIS 52 0.0016
357 KNEE OPERATION 16 0.0016
358 ULCER HAEMORRHAGE 11 0.0016
359 DYSPNOEA EXERTIONAL 61 0.0016
360 COVID-19 284 0.0016
361 MULTIPLE DRUG OVERDOSE 8 0.0016
362 COVID-19 PNEUMONIA 19 0.0016
363 PRODUCT LEAKAGE 9 0.0016
364 HEPATIC ENZYME ABNORMAL 8 0.0016
365 MUSCULOSKELETAL STIFFNESS 140 0.0016
366 SECRETION DISCHARGE 20 0.0016
367 DYSPHEMIA 7 0.0016
368 LYMPHOEDEMA 11 0.0016
369 MITRAL VALVE INCOMPETENCE 18 0.0016
370 DRY MOUTH 129 0.0016
371 SPUTUM DISCOLOURED 15 0.0016
372 DECREASED ACTIVITY 17 0.0016
373 CARDIAC VALVE DISEASE 9 0.0016
374 SLUGGISHNESS 16 0.0016
375 SNEEZING 35 0.0016
376 CHRONIC KIDNEY DISEASE 118 0.0016
377 HAND FRACTURE 11 0.0016
378 PSORIATIC ARTHROPATHY 63 0.0016
379 TRISMUS 8 0.0015
380 VARICOSE VEIN 8 0.0015
381 DRY EYE 77 0.0015
382 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 10 0.0015
383 RESPIRATORY DISORDER 46 0.0015
384 DISEASE COMPLICATION 7 0.0015
385 EAR DISORDER 7 0.0015
386 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
387 DYSPAREUNIA 7 0.0015
388 PANIC REACTION 11 0.0015
389 STOMATITIS 92 0.0015
390 SCRATCH 16 0.0015
391 HYPOKINESIA 22 0.0015
392 TYPE 2 DIABETES MELLITUS 51 0.0015
393 TRICUSPID VALVE INCOMPETENCE 12 0.0015
394 MAJOR DEPRESSION 11 0.0015
395 SKIN SWELLING 13 0.0015
396 BODY HEIGHT DECREASED 16 0.0015
397 LACRIMATION INCREASED 45 0.0015
398 PARAESTHESIA 234 0.0015
399 STAPHYLOCOCCAL INFECTION 49 0.0015
400 ROAD TRAFFIC ACCIDENT 62 0.0015
401 LEUKOPENIA 74 0.0015
402 HIP SURGERY 8 0.0015
403 ABDOMINAL PAIN UPPER 304 0.0015
404 DRY THROAT 15 0.0015
405 INTENTIONAL DOSE OMISSION 42 0.0015
406 INFLAMMATION 76 0.0015
407 NORMAL NEWBORN 8 0.0015
408 NASAL CONGESTION 86 0.0015
409 CARDIO-RESPIRATORY ARREST 61 0.0015
410 ECCHYMOSIS 10 0.0015
411 CORONARY ARTERY OCCLUSION 20 0.0015
412 FACIAL PAIN 13 0.0015
413 CONTUSION 140 0.0015
414 SPINAL PAIN 17 0.0014
415 JOINT EFFUSION 10 0.0014
416 CELLULITIS 73 0.0014
417 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 75 0.0014
418 PERIPHERAL SWELLING 221 0.0014
419 IMPAIRED HEALING 47 0.0014
420 FEEDING DISORDER 29 0.0014
421 THERAPEUTIC PRODUCT EFFECT DECREASED 64 0.0014
422 FATIGUE 1110 0.0014
423 LIMB DISCOMFORT 44 0.0014
424 DEVICE OCCLUSION 20 0.0014
425 WRIST FRACTURE 17 0.0014
426 DRUG EFFECT LESS THAN EXPECTED 21 0.0014
427 PAIN IN JAW 40 0.0014
428 NASOPHARYNGITIS 260 0.0014
429 SWELLING 132 0.0014
430 FUNGAL INFECTION 47 0.0014
431 PSEUDOMONAS INFECTION 12 0.0014
432 INJURY 98 0.0014
433 BACTERIAL INFECTION 26 0.0014
434 COMPLETED SUICIDE 116 0.0014
435 HEAD INJURY 44 0.0014
436 PSYCHOLOGICAL TRAUMA 12 0.0014
437 FURUNCLE 11 0.0014
438 FLANK PAIN 13 0.0014
439 PRODUCT ADMINISTRATION ERROR 28 0.0014
440 HEPATIC CIRRHOSIS 26 0.0014
441 SKIN FISSURES 27 0.0014
442 KNEE ARTHROPLASTY 29 0.0014
443 ORAL CANDIDIASIS 18 0.0014
444 GASTROINTESTINAL DISORDER 122 0.0014
445 URINE ODOUR ABNORMAL 8 0.0014
446 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
447 PULMONARY FIBROSIS 26 0.0014
448 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
449 NERVE INJURY 15 0.0013
450 RHINORRHOEA 87 0.0013
451 SCAR 23 0.0013
452 MYOSITIS 12 0.0013
453 ARTHRITIS 105 0.0013
454 VITAMIN D DEFICIENCY 13 0.0013
455 PRODUCT TASTE ABNORMAL 18 0.0013
456 OROPHARYNGEAL DISCOMFORT 12 0.0013
457 VIRAL INFECTION 44 0.0013
458 DYSPEPSIA 130 0.0013
459 INFLUENZA 147 0.0013
460 OROPHARYNGEAL PAIN 122 0.0013
461 THERAPY NON-RESPONDER 59 0.0013
462 NEPHROLITHIASIS 60 0.0013
463 RESPIRATION ABNORMAL 9 0.0013
464 MUSCLE SPASMS 239 0.0013
465 GINGIVITIS 7 0.0013
466 ORAL PAIN 29 0.0013
467 OEDEMA 70 0.0013
468 ANKYLOSING SPONDYLITIS 17 0.0013
469 PAIN IN EXTREMITY 380 0.0013
470 APHONIA 18 0.0013
471 EMPHYSEMA 13 0.0013
472 PYREXIA 441 0.0013
473 THROAT IRRITATION 57 0.0013
474 INITIAL INSOMNIA 13 0.0013
475 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 228 0.0013
476 CYSTIC FIBROSIS 7 0.0013
477 BLOOD IRON DECREASED 15 0.0013
478 BONE DISORDER 23 0.0013
479 JOINT STIFFNESS 33 0.0013
480 GASTRITIS 33 0.0013
481 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
482 PRESCRIBED UNDERDOSE 25 0.0013
483 POST PROCEDURAL COMPLICATION 24 0.0012
484 PARAESTHESIA ORAL 18 0.0012
485 CHEST PAIN 231 0.0012
486 HEART RATE INCREASED 123 0.0012
487 SKIN ULCER 32 0.0012
488 HIATUS HERNIA 16 0.0012
489 NOCTURIA 15 0.0012
490 THYROID DISORDER 19 0.0012
491 DEPRESSED MOOD 65 0.0012
492 TENDON DISORDER 8 0.0012
493 POLYP 8 0.0012
494 CEREBRAL DISORDER 9 0.0012
495 RASH 530 0.0012
496 SKIN HAEMORRHAGE 18 0.0012
497 DYSGRAPHIA 8 0.0012
498 PHARYNGITIS 15 0.0012
499 CATARACT 72 0.0012
500 BLOOD PRESSURE ABNORMAL 24 0.0012
501 NEEDLE ISSUE 35 0.0012
502 HEART RATE IRREGULAR 27 0.0012
503 INTESTINAL OBSTRUCTION 45 0.0012
504 ABSCESS 19 0.0012
505 ECONOMIC PROBLEM 18 0.0012
506 OSTEOPENIA 18 0.0012
507 LABORATORY TEST ABNORMAL 35 0.0012
508 PRODUCT AVAILABILITY ISSUE 27 0.0012
509 MUSCULOSKELETAL PAIN 62 0.0012
510 IMPAIRED QUALITY OF LIFE 17 0.0012
511 INTENTIONAL PRODUCT USE ISSUE 103 0.0012
512 VITAMIN D DECREASED 10 0.0012
513 COUGH 327 0.0012
514 BLOOD POTASSIUM DECREASED 35 0.0012
515 EYE IRRITATION 67 0.0012
516 DISABILITY 23 0.0012
517 ONYCHOCLASIS 8 0.0012
518 POOR QUALITY SLEEP 25 0.0012
519 PRODUCT USE IN UNAPPROVED INDICATION 287 0.0012
520 TRANSIENT ISCHAEMIC ATTACK 39 0.0012
521 THERAPY PARTIAL RESPONDER 18 0.0012
522 PROCEDURAL PAIN 32 0.0012
523 SOMNOLENCE 232 0.0012
524 HYPERSOMNIA 33 0.0011
525 ABDOMINAL DISCOMFORT 193 0.0011
526 FORMICATION 8 0.0011
527 COORDINATION ABNORMAL 16 0.0011
528 BONE PAIN 67 0.0011
529 PRODUCT USE COMPLAINT 18 0.0011
530 MUSCLE SPASTICITY 14 0.0011
531 MOUTH ULCERATION 24 0.0011
532 CHOLECYSTECTOMY 13 0.0011
533 HERNIA 22 0.0011
534 ARTHRALGIA 473 0.0011
535 NASAL DISCOMFORT 9 0.0011
536 RENAL CYST 9 0.0011
537 WEIGHT DECREASED 316 0.0011
538 NEOPLASM 13 0.0011
539 GINGIVAL PAIN 9 0.0011
540 EYE SWELLING 42 0.0011
541 HAEMORRHOIDS 22 0.0011
542 CHOKING 22 0.0011
543 METASTASIS 8 0.0011
544 VITREOUS FLOATERS 11 0.0011
545 QUALITY OF LIFE DECREASED 15 0.0011
546 DEPRESSION 253 0.0011
547 BLOOD PRESSURE INCREASED 170 0.0011
548 HEART RATE DECREASED 39 0.0011
549 DRUG ABUSE 92 0.0011
550 LIVER INJURY 27 0.0011
551 DISCOMFORT 67 0.0011
552 ASPIRATION 12 0.0011
553 WEIGHT INCREASED 245 0.0011
554 OSTEOPOROSIS 45 0.0011
555 GAIT DISTURBANCE 208 0.0011
556 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
557 DENTAL CARIES 12 0.0011
558 CARDIAC FLUTTER 7 0.0011
559 EATING DISORDER 23 0.0011
560 BODY TEMPERATURE INCREASED 22 0.0011
561 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
562 THERAPY INTERRUPTED 77 0.0011
563 FEELING DRUNK 8 0.0011
564 PNEUMONIA 348 0.0011
565 PULMONARY MASS 16 0.0011
566 THINKING ABNORMAL 20 0.0011
567 EYE PRURITUS 36 0.0011
568 HYPONATRAEMIA 60 0.0011
569 MUSCULAR WEAKNESS 121 0.0011
570 GALLBLADDER DISORDER 19 0.0011
571 DYSARTHRIA 40 0.0011
572 IMMUNE SYSTEM DISORDER 14 0.0011
573 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
574 INSOMNIA 281 0.0011
575 UPPER LIMB FRACTURE 21 0.0011
576 SCAB 12 0.0011
577 MUSCULOSKELETAL DISORDER 20 0.0010
578 CYST 13 0.0010
579 DIVERTICULITIS 29 0.0010
580 BOWEL MOVEMENT IRREGULARITY 8 0.0010
581 SKIN DISCOLOURATION 48 0.0010
582 C-REACTIVE PROTEIN INCREASED 38 0.0010
583 PANCREATITIS 55 0.0010
584 PAIN OF SKIN 28 0.0010
585 RENAL PAIN 11 0.0010
586 ATRIOVENTRICULAR BLOCK 8 0.0010
587 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
588 APHTHOUS ULCER 8 0.0010
589 NEUROPATHY PERIPHERAL 98 0.0010
590 URINE OUTPUT DECREASED 9 0.0010
591 DRUG TOXICITY 14 0.0010
592 THERAPEUTIC RESPONSE SHORTENED 34 0.0010
593 ORAL HERPES 20 0.0010
594 DYSPNOEA 579 0.0010
595 PHARYNGEAL SWELLING 10 0.0010
596 MIDDLE INSOMNIA 19 0.0010
597 RESPIRATORY RATE INCREASED 9 0.0010
598 BURNING SENSATION 71 0.0010
599 INABILITY TO AFFORD MEDICATION 10 0.0010
600 DERMATITIS ATOPIC 53 0.0010
601 GOUT 18 0.0010
602 SPINAL FRACTURE 20 0.0010
603 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 71 0.0010
604 HOT FLUSH 75 0.0010
605 SENSORY LOSS 8 0.0010
606 RHINITIS 8 0.0010
607 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
608 PELVIC PAIN 18 0.0010
609 OCULAR HYPERAEMIA 47 0.0010
610 BEDRIDDEN 13 0.0010
611 MUSCLE DISORDER 8 0.0010
612 SARS-COV-2 TEST POSITIVE 13 0.0010
613 HIP ARTHROPLASTY 15 0.0010
614 IRON DEFICIENCY ANAEMIA 9 0.0010
615 TENDONITIS 15 0.0010
616 OEDEMA PERIPHERAL 118 0.0010
617 ANXIETY 275 0.0010
618 MOVEMENT DISORDER 31 0.0010
619 DEFORMITY 9 0.0010
620 EYE DISCHARGE 10 0.0010
621 INJECTION SITE DISCOLOURATION 12 0.0010
622 ABDOMINAL DISTENSION 100 0.0010
623 NAUSEA 758 0.0010
624 HERPES ZOSTER 55 0.0010
625 MATERNAL EXPOSURE DURING PREGNANCY 85 0.0010
626 AMNESIA 62 0.0010
627 GINGIVAL BLEEDING 13 0.0010
628 ACUTE MYOCARDIAL INFARCTION 28 0.0009
629 VOMITING 446 0.0009
630 MULTIPLE SCLEROSIS RELAPSE 65 0.0009
631 RESPIRATORY ARREST 26 0.0009
632 INJECTION SITE IRRITATION 12 0.0009
633 ANGINA PECTORIS 27 0.0009
634 EMOTIONAL DISORDER 29 0.0009
635 VISION BLURRED 129 0.0009
636 ATAXIA 11 0.0009
637 MUSCLE TIGHTNESS 15 0.0009
638 CARDIAC MURMUR 8 0.0009
639 DELIRIUM 32 0.0009
640 BIPOLAR DISORDER 10 0.0009
641 RENAL TUBULAR NECROSIS 9 0.0009
642 HEPATOMEGALY 9 0.0009
643 HOSPICE CARE 9 0.0009
644 GROIN PAIN 8 0.0009
645 PHOTOSENSITIVITY REACTION 15 0.0009
646 ARRHYTHMIA 43 0.0009
647 DYSPHONIA 53 0.0009
648 LYMPHOMA 14 0.0009
649 BLOOD SODIUM DECREASED 17 0.0009
650 FEELING ABNORMAL 216 0.0009
651 OVARIAN CYST 9 0.0009
652 SKIN DISORDER 30 0.0009
653 DIZZINESS 447 0.0009
654 OFF LABEL USE 782 0.0009
655 ANAL INCONTINENCE 8 0.0009
656 DRUG SCREEN POSITIVE 7 0.0009
657 MOTOR DYSFUNCTION 9 0.0009
658 PNEUMOTHORAX 14 0.0009
659 THROMBOSIS 71 0.0009
660 PRURITUS 339 0.0009
661 ATRIAL FLUTTER 7 0.0009
662 ALOPECIA 172 0.0009
663 INCREASED TENDENCY TO BRUISE 8 0.0009
664 DYSURIA 32 0.0009
665 URINARY RETENTION 29 0.0009
666 MENTAL IMPAIRMENT 21 0.0009
667 PERICARDIAL EFFUSION 20 0.0009
668 PULMONARY HYPERTENSION 18 0.0009
669 INFLUENZA LIKE ILLNESS 71 0.0009
670 RECTAL HAEMORRHAGE 37 0.0009
671 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
672 DECUBITUS ULCER 7 0.0009
673 CONDITION AGGRAVATED 261 0.0009
674 INJECTION SITE DISCOMFORT 9 0.0009
675 EPISTAXIS 64 0.0009
676 CHOLELITHIASIS 28 0.0009
677 PANIC ATTACK 31 0.0008
678 EXPOSURE VIA SKIN CONTACT 22 0.0008
679 FULL BLOOD COUNT DECREASED 17 0.0008
680 SKIN EXFOLIATION 71 0.0008
681 CHEST DISCOMFORT 86 0.0008
682 DIARRHOEA 542 0.0008
683 FEMUR FRACTURE 26 0.0008
684 RED BLOOD CELL COUNT DECREASED 24 0.0008
685 ACCIDENT 10 0.0008
686 DYSPHAGIA 79 0.0008
687 FLATULENCE 47 0.0008
688 TOOTHACHE 15 0.0008
689 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
690 CRYING 30 0.0008
691 PULMONARY THROMBOSIS 9 0.0008
692 LOSS OF CONSCIOUSNESS 105 0.0008
693 ASTHENIA 308 0.0008
694 COMA 39 0.0008
695 INJECTION SITE NODULE 9 0.0008
696 RENAL FAILURE 108 0.0008
697 CARDIAC DISORDER 76 0.0008
698 BLOOD MAGNESIUM DECREASED 7 0.0008
699 CONJUNCTIVITIS 15 0.0008
700 SUICIDAL IDEATION 74 0.0008
701 HAEMATOCRIT DECREASED 16 0.0008
702 MOOD ALTERED 22 0.0008
703 HEPATIC STEATOSIS 15 0.0008
704 PULMONARY OEDEMA 36 0.0008
705 ABDOMINAL PAIN 186 0.0008
706 DISTURBANCE IN ATTENTION 43 0.0008
707 HYPOXIA 28 0.0008
708 COLD SWEAT 14 0.0008
709 NEOPLASM MALIGNANT 53 0.0008
710 CHILLS 93 0.0008
711 ABDOMINAL PAIN LOWER 20 0.0008
712 HUNGER 11 0.0008
713 MYALGIA 134 0.0008
714 NERVOUSNESS 41 0.0008
715 ECZEMA 41 0.0008
716 HEPATITIS 20 0.0008
717 MENTAL DISORDER 34 0.0008
718 CONFUSIONAL STATE 126 0.0008
719 PARALYSIS 11 0.0008
720 DECREASED APPETITE 178 0.0008
721 LETHARGY 44 0.0008
722 DEHYDRATION 102 0.0008
723 ANHEDONIA 20 0.0008
724 ANAPHYLACTIC REACTION 42 0.0008
725 PALPITATIONS 89 0.0008
726 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
727 INCONTINENCE 8 0.0008
728 MYOCARDIAL INFARCTION 132 0.0008
729 VERTIGO 46 0.0008
730 CHROMATURIA 17 0.0008
731 NIGHTMARE 26 0.0008
732 INJECTION SITE RASH 23 0.0007
733 HIP FRACTURE 24 0.0007
734 MALAISE 327 0.0007
735 HEPATITIS C 9 0.0007
736 LIVER DISORDER 33 0.0007
737 TACHYCARDIA 66 0.0007
738 ILL-DEFINED DISORDER 45 0.0007
739 FREQUENT BOWEL MOVEMENTS 20 0.0007
740 INJECTION SITE PAIN 226 0.0007
741 GASTRIC ULCER 14 0.0007
742 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
743 TREMOR 122 0.0007
744 FEELING JITTERY 14 0.0007
745 LYMPHADENOPATHY 26 0.0007
746 HEAD DISCOMFORT 13 0.0007
747 URTICARIA 123 0.0007
748 EYE INFLAMMATION 7 0.0007
749 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
750 SMALL INTESTINAL OBSTRUCTION 9 0.0007
751 EYE DISORDER 24 0.0007
752 TENDON RUPTURE 9 0.0007
753 ACUTE RESPIRATORY FAILURE 14 0.0007
754 GASTROINTESTINAL PAIN 8 0.0007
755 GLAUCOMA 14 0.0007
756 DRUG INTERACTION 115 0.0007
757 CARDIAC FAILURE CONGESTIVE 58 0.0007
758 HYPOTHYROIDISM 23 0.0007
759 FLUSHING 73 0.0007
760 FEELING HOT 44 0.0007
761 HALLUCINATION 54 0.0007
762 RASH MACULAR 25 0.0007
763 THERAPEUTIC RESPONSE DECREASED 43 0.0007
764 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
765 CYANOSIS 11 0.0007
766 DEEP VEIN THROMBOSIS 45 0.0007
767 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
768 SYNCOPE 69 0.0007
769 RENAL DISORDER 32 0.0007
770 VASCULITIS 8 0.0007
771 VISUAL IMPAIRMENT 85 0.0007
772 APATHY 10 0.0007
773 DYSSTASIA 20 0.0007
774 ADVERSE EVENT 63 0.0007
775 HOSPITALISATION 105 0.0007
776 EUPHORIC MOOD 7 0.0007
777 FEELING COLD 19 0.0007
778 DIABETES MELLITUS 52 0.0007
779 EAR DISCOMFORT 7 0.0007
780 INJECTION SITE BRUISING 54 0.0007
781 SEROTONIN SYNDROME 13 0.0007
782 CARDIOMYOPATHY 10 0.0007
783 TREATMENT NONCOMPLIANCE 37 0.0007
784 URINARY INCONTINENCE 20 0.0007
785 TOOTH DISORDER 15 0.0007
786 GENERAL PHYSICAL HEALTH DETERIORATION 78 0.0007
787 HAIR TEXTURE ABNORMAL 9 0.0007
788 SWOLLEN TONGUE 21 0.0007
789 CHOLECYSTITIS 8 0.0007
790 METASTASES TO BONE 11 0.0007
791 MULTIPLE SCLEROSIS 32 0.0007
792 ACUTE KIDNEY INJURY 102 0.0007
793 THROAT TIGHTNESS 18 0.0007
794 BONE LOSS 10 0.0007
795 RASH PRURITIC 36 0.0007
796 APHASIA 20 0.0007
797 FULL BLOOD COUNT ABNORMAL 7 0.0007
798 CEREBROVASCULAR ACCIDENT 112 0.0007
799 UNEVALUABLE EVENT 50 0.0007
800 PRESYNCOPE 16 0.0007
801 DEVICE FAILURE 10 0.0007
802 BREAST PAIN 7 0.0007
803 ACCIDENTAL OVERDOSE 24 0.0007
804 ABNORMAL DREAMS 18 0.0007
805 DRUG INEFFECTIVE 858 0.0007
806 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
807 CARDIAC FAILURE 52 0.0006
808 HAEMOPTYSIS 18 0.0006
809 DRY SKIN 86 0.0006
810 SUICIDE ATTEMPT 39 0.0006
811 TOOTH EXTRACTION 8 0.0006
812 COLITIS 24 0.0006
813 BLOOD URINE PRESENT 12 0.0006
814 BLOOD PRESSURE DECREASED 42 0.0006
815 FEAR 17 0.0006
816 RENAL IMPAIRMENT 53 0.0006
817 POLLAKIURIA 26 0.0006
818 SKIN LESION 17 0.0006
819 HAEMATOMA 16 0.0006
820 DIPLOPIA 16 0.0006
821 THIRST 11 0.0006
822 MENTAL STATUS CHANGES 17 0.0006
823 INJECTION SITE PRURITUS 41 0.0006
824 INJECTION SITE URTICARIA 15 0.0006
825 DEMENTIA 17 0.0006
826 PULMONARY CONGESTION 8 0.0006
827 SKIN CANCER 13 0.0006
828 ADVERSE DRUG REACTION 54 0.0006
829 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
830 INJECTION SITE MASS 22 0.0006
831 HEMIPARESIS 10 0.0006
832 TINNITUS 27 0.0006
833 INCREASED APPETITE 11 0.0006
834 INJECTION SITE SWELLING 44 0.0006
835 DERMATITIS 12 0.0006
836 RENAL INJURY 17 0.0006
837 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
838 ULCER 9 0.0006
839 GENERALISED OEDEMA 7 0.0006
840 SEPSIS 63 0.0006
841 IMPAIRED WORK ABILITY 12 0.0006
842 BRONCHOSPASM 8 0.0006
843 INJECTION SITE ERYTHEMA 69 0.0006
844 SPEECH DISORDER 29 0.0006
845 DEVICE DISLOCATION 24 0.0006
846 CARDIOVASCULAR DISORDER 14 0.0006
847 PRODUCT PRESCRIBING ISSUE 12 0.0006
848 GASTROENTERITIS 8 0.0005
849 WITHDRAWAL SYNDROME 23 0.0005
850 ANAEMIA 104 0.0005
851 BLOOD GLUCOSE DECREASED 26 0.0005
852 DYSKINESIA 22 0.0005
853 LIP SWELLING 18 0.0005
854 PULMONARY EMBOLISM 51 0.0005
855 FACE OEDEMA 9 0.0005
856 DISORIENTATION 21 0.0005
857 THERAPY CESSATION 27 0.0005
858 EYE HAEMORRHAGE 7 0.0005
859 AGEUSIA 13 0.0005
860 DEVICE RELATED INFECTION 8 0.0005
861 RESTLESSNESS 19 0.0005
862 HYPOPHAGIA 13 0.0005
863 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
864 CONVULSION 29 0.0005
865 SWELLING FACE 33 0.0005
866 ISCHAEMIC STROKE 9 0.0005
867 UNRESPONSIVE TO STIMULI 13 0.0005
868 ANGER 17 0.0005
869 PREGNANCY 10 0.0005
870 IRRITABILITY 30 0.0005
871 DYSGEUSIA 37 0.0005
872 RESPIRATORY FAILURE 36 0.0005
873 BLOOD POTASSIUM INCREASED 8 0.0005
874 ENCEPHALOPATHY 12 0.0005
875 INCORRECT DOSE ADMINISTERED 111 0.0005
876 INJECTION SITE WARMTH 10 0.0005
877 CARDIAC ARREST 40 0.0005
878 TOOTH LOSS 10 0.0005
879 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
880 INJECTION SITE REACTION 33 0.0005
881 RHABDOMYOLYSIS 20 0.0005
882 DEVICE ISSUE 43 0.0005
883 PLATELET COUNT DECREASED 51 0.0005
884 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
885 FRACTURE 9 0.0005
886 ATRIAL FIBRILLATION 46 0.0005
887 HAEMATOCHEZIA 26 0.0005
888 GASTRIC DISORDER 16 0.0005
889 ERUCTATION 9 0.0005
890 EMOTIONAL DISTRESS 56 0.0005
891 BLOOD COUNT ABNORMAL 7 0.0005
892 FAECES DISCOLOURED 10 0.0005
893 DEVICE USE ERROR 16 0.0005
894 SEIZURE 53 0.0005
895 LOCAL SWELLING 8 0.0005
896 LYMPHOCYTE COUNT DECREASED 8 0.0005
897 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
898 DELUSION 7 0.0005
899 AGITATION 33 0.0004
900 NERVOUS SYSTEM DISORDER 14 0.0004
901 RENAL FAILURE ACUTE 19 0.0004
902 PRODUCT PHYSICAL ISSUE 9 0.0004
903 PLEURAL EFFUSION 27 0.0004
904 LEUKOCYTOSIS 8 0.0004
905 PRODUCT QUALITY ISSUE 60 0.0004
906 PNEUMONITIS 12 0.0004
907 RESPIRATORY DISTRESS 12 0.0004
908 HYPOKALAEMIA 20 0.0004
909 HAEMORRHAGE 45 0.0004
910 HAEMOGLOBIN DECREASED 44 0.0004
911 HALLUCINATION, VISUAL 9 0.0004
912 DEAFNESS 11 0.0004
913 MUCOSAL INFLAMMATION 11 0.0004
914 ANGIOEDEMA 18 0.0004
915 INTENTIONAL OVERDOSE 26 0.0004
916 ERECTILE DYSFUNCTION 10 0.0004
917 UNDERDOSE 28 0.0004
918 INTENTIONAL DRUG MISUSE 8 0.0004
919 DRUG-INDUCED LIVER INJURY 12 0.0004
920 DISEASE RECURRENCE 18 0.0004
921 PRODUCT PRESCRIBING ERROR 9 0.0004
922 METABOLIC ACIDOSIS 12 0.0004
923 NEOPLASM PROGRESSION 13 0.0004
924 HYPOACUSIS 16 0.0004
925 DRUG EFFECT DECREASED 20 0.0004
926 ACCIDENTAL EXPOSURE TO PRODUCT 38 0.0004
927 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
928 DRUG PRESCRIBING ERROR 7 0.0004
929 MEDICATION ERROR 20 0.0004
930 RASH PAPULAR 8 0.0004
931 BONE DENSITY DECREASED 11 0.0004
932 HAEMATURIA 12 0.0004
933 MOOD SWINGS 11 0.0003
934 BLOOD GLUCOSE INCREASED 65 0.0003
935 PRODUCT ADHESION ISSUE 12 0.0003
936 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 68 0.0003
937 PALLOR 9 0.0003
938 SKIN IRRITATION 15 0.0003
939 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
940 OSTEONECROSIS OF JAW 8 0.0003
941 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
942 PANCYTOPENIA 18 0.0003
943 EXTRA DOSE ADMINISTERED 13 0.0003
944 DEVICE BREAKAGE 13 0.0003
945 PNEUMONIA ASPIRATION 8 0.0003
946 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
947 OSTEONECROSIS 10 0.0003
948 ACNE 23 0.0003
949 ABNORMAL BEHAVIOUR 12 0.0003
950 HYPERGLYCAEMIA 11 0.0003
951 EXPIRED PRODUCT ADMINISTERED 10 0.0003
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
953 BLINDNESS 12 0.0003
954 BLOOD CREATININE INCREASED 19 0.0003
955 INJECTION SITE HAEMORRHAGE 23 0.0003
956 ABASIA 7 0.0003
957 PLASMA CELL MYELOMA 11 0.0003
958 AGGRESSION 14 0.0003
959 PRODUCT DOSE OMISSION 18 0.0003
960 DRUG EFFECT INCOMPLETE 10 0.0003
961 PSYCHOTIC DISORDER 8 0.0003
962 NEUTROPHIL COUNT DECREASED 11 0.0003
963 INTERSTITIAL LUNG DISEASE 13 0.0003
964 SKIN BURNING SENSATION 19 0.0003
965 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
966 DEATH 222 0.0003
967 HYPERKALAEMIA 9 0.0003
968 DISEASE PROGRESSION 30 0.0003
969 NEUTROPENIA 34 0.0002
970 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
971 DEVICE MALFUNCTION 17 0.0002
972 ASCITES 7 0.0002
973 DEVICE LEAKAGE 10 0.0002
974 SEPTIC SHOCK 10 0.0002
975 DRUG ADMINISTRATION ERROR 7 0.0002
976 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
977 LUNG NEOPLASM MALIGNANT 9 0.0002
978 PRODUCT STORAGE ERROR 19 0.0002
979 DRUG WITHDRAWAL SYNDROME 19 0.0002
980 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
981 DRUG DOSE OMISSION 35 0.0002
982 BRADYCARDIA 11 0.0002
983 VAGINAL HAEMORRHAGE 9 0.0002
984 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
985 HYPOGLYCAEMIA 9 0.0002
986 NO ADVERSE EVENT 33 0.0002
987 DEVICE DIFFICULT TO USE 12 0.0002
988 COLITIS ULCERATIVE 8 0.0002
989 PRODUCT SUBSTITUTION ISSUE 8 0.0001
990 DRUG DEPENDENCE 22 0.0001
991 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
992 DEVICE EXPULSION 7 0.0001
993 PROSTATE CANCER 8 0.0001
994 BREAST CANCER 9 0.0001